Vertos Medical Blog

Learn & Earn CME: Opportunities for Continued Education with the mild® Procedure

Interested in continuing medical education (CME) through didactic lectures, discussions and a compendium of case reviews from other leading experts? Find a list of webinars and webcasts from reputable societies, including American Society of Pain & Neuroscience (ASPN), Pacific Spine & Pain Society (PSPS), Women Innovators in Pain Management (WIPM) and Florida Society of Pain and Neuroscience (FSPN) below to learn more about identifying and treating patients with the mild® Procedure, commonly referred to in the CME setting as Percutaneous Image-Guided Lumbar Decompression (PILD).

Free On-Demand Webcasts Actively Available for CME Credit

Women Innovators in Pain Management Webinar: Expanding Opportunities to Treat LSS Patients Earlier & More Often with PILD

Dec. 2020

In this Women Innovators in Pain Management (WIPM) webinar, moderator Jacqueline Weisbein, DO and faculty members Jessica Jameson, MD and FASA Lindsay N. Shroyer, MD discuss how to evaluate patients to determine appropriate candidates for PILD, use safety and efficacy data to understand where PILD fits in the LSS treatment algorithm, understand basic tenants and advantages of the Streamlined Technique and apply best practices for forging relationships with surgeon colleagues to help more patients.

“This procedure, you know, it’s not just for patients with stenosis… It’s performed with patients with stenosis, but they have other comorbidities… In my patients that are 70 years and older, they have facet arthropathy, they have stenosis, they have disc bulge and having those other conditions doesn’t make this a contraindication. You can still do this procedure on patients with those other comorbidities as long as they have greater than 2.5 millimeters of ligamentum flavum hypertrophy,” Dr. Shroyer says.

Educational activity is jointly provided by Dannemiller and Women Innovators in Pain Management (WIPM) and is available for CME credit until its expiration date of December 10, 2021.

ASPN CME Webinar Series: Reviewing MRIs: A Collaborative Approach to Patient Selection

June 2021

In this American Society of Pain & Neuroscience (ASPN) webinar, moderators Timothy Deer, MD; Dawood Sayed, MD and faculty members Navdeep Jassal, MD; Eugene Paik, MD; Ashley Comer, NP-C; Christine Christensen, APRN; and Zohra Hussaini, MSN, FNP-BC, MBA, APRN discuss how physicians and APPs can match more patients with the right treatments sooner by working together.

“I don’t think it matters what state regulation exists. That communication, and that shared respect and trust, and the relationship you build, is really independent of what your restrictions might be. If you’re in a collaborative practice state where you have to have a collaborative agreement, or if you’re an independent practice state where you don’t have to have that collaborative practice agreement, I think equally you’re going to have to collaborate with your team to make patient outcomes positive,” Zohra Hussaini says.

Educational activity is jointly provided by Evolve Medical Education, LLC and Mantra Meetings, and is available for CME credit until its expiration date of June 23, 2022.

Additional Free On-Demand Education

ASPN CME Webinar Series: New Perspectives on Treating Spinal Stenosis with PILD – Evolving the Treatment Algorithm

July 2020

In this American Society of Pain & Neuroscience (ASPN) webinar, moderators Timothy Deer, MD; Dawood Sayed, MD and faculty members Steven Falowski, MD; Anjum Bux, MD; Peter Pryzbylkowski, MD; Navdeep Jassal, MD; Alex Escobar, MD and Zohra Hussaini, MSN, FNP-BC, MBA, discuss how to evaluate patients to determine appropriate candidates for PILD, use safety and efficacy data to understand where PILD fits in the LSS treatment algorithm, and efficiently educate and manage PILD patients to ensure appropriate treatment expectations are established.

“We know that the effect of epidural steroid injections (ESIs) on symptoms of neurogenic claudication (NC) are limited and they’re short term and, as Anjum mentioned earlier, patients receiving steroids do have increased susceptibility to infection and immunosuppression. So, the great thing about this procedure, you don’t have to use steroids. If you’re worried about taking referrals from your surgical colleagues, I’d encourage you to go to your surgical colleagues and say, ‘Give me the patients you don’t want to operate on and see what I can do for them.’ You’ll be impressed and the patients will go back to those surgeons and then all of a sudden, you’ll see surgeons start to refer more and more to you for patients they don’t want to operate on. You can truly help when you do the decompression procedure. So, spinal comorbidities are not contraindicated, so if patients have disc bulges, disc osteophytes, facet arthropathy, facet hypertrophy, that doesn’t preclude those patients from getting a percutaneous decompression, those patients tend to do very well after we decompress them,” Dr. Pryzbylkowski says.

ASPN Virtual Think Tank Session 5: Minimally Invasive Spine Therapies

Aug. 2020

In this ASPN Virtual Think Tank, moderators Timothy Deer, MD and Dawood Sayed, MD discuss minimally invasive procedures for the spine, proper methods of patient selection for interventional pain techniques, and safety and efficacy of patients going forward. The Vertos Medical session, “Redefining the mild® Procedure: Emerging Techniques & Advancing the Treatment Algorithm” is led by Alex Escobar, MD; Denis G. Patterson, DO and Jackie Weisbein, DO.

“One of the many features that we see with innovation comes around optimizing techniques and not recreating something new and what we’ve found through many hours spent in the cadaver lab as well as employing this Streamlined Technique in many of our practices is that we can commonly access both sides of the lamina using the single entry point that we will see in a video shortly.” Dr. Escobar says.

FSPN Spinal Stenosis: Novel, Evidence-Based Treatments Webinar

Sept. 2020

In this Florida Society of Pain and Neuroscience webinar, moderator Steven Falowski, MD and faculty members Nomen Azeem, MD; Michael Esposito, MD; Jackie Weisbein, DO; Stanley Golovac, MD; Navdeep Jassal, MD and Miguel Attias, MD discuss pathogenesis of LSS, spinal stenosis treatment algorithm, Vertos Medical’s mild® Procedure and more.

“We’re at a very pivotable point in terms of interventional pain. We’re crossing into the crossroads of interventional spine or minimally invasive spine, so let’s progress forward,” Dr. Jassal shares.

PSPS Expanding Opportunities to Treat LSS Patients Earlier & More Often with PILD

Sept. 2020

In this Pacific Spine & Pain Society (PSPS) training webinar, moderator Jason Pope, MD, and faculty members Steven Falowski, MD; Denis Patterson, DO and Jacqueline Weisbein, DO discuss how to evaluate patients to determine appropriate candidates for PILD, use safety and efficacy data to understand where PILD fits in the LSS treatment algorithm, understand basic tenants and advantages of the technique and apply best practices for forging relationships with surgeon colleagues to help more patients.

“We have highly under-treated lumbar spinal stenosis patients and the idea of just being able to either offer epidural steroid injections (ESIs) or jumping right to surgery is, I think, becoming a thing of the past and it’s not going to be part of our algorithm in that same manner,” Dr. Falowski says.

Rationale and Best Practices for Lumbar Spinal Stenosis (LSS) Identifying and Treating Patients with the mild® Procedure

In this five-part webcast series from Ciné-Med and MediaSphere Medical, Timothy Deer, MD, DABPM, FIPP; Stanley Golovac, MD; Navdeep Jassal, MD and Ashley Comer, APRN, NP-C discuss lumbar spinal stenosis and treatment options, typical lumbar spinal stenosis patients and differentiating symptom types, confirming symptoms with an MRI, integrating LSS identification and efficient patient management into a practice’s routine, and FAQ with those that are mild® providers.

“This activity evaluates the promising strategy of the reimbursable mild® Procedure for treating LSS patients minimally invasively, which restores mobility and reduces pain, while offering a low risk of major complications,” the activity description reads.

Collaboration is one of Vertos Medical’s core values as the company partners with the nation’s leading institutions and healthcare providers to ensure LSS patients have access to mild® as a treatment option. Performed through an incision smaller than the size of a baby aspirin (5.1mm), mild® is a minimally invasive lumbar decompression procedure that removes a major root cause of neurogenic claudication by debulking the hypertrophic ligamentum flavum, which reduces the compression of the nerves. Learn more about how mild® can be a valuable part of your practice.

© 2021 Vertos Medical, Inc. All Rights Reserved.